Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Gail Herman, Matt Posard, More

Premium

Gail Herman has been elected president of the American College of Medical Genetics and Genomics, replacing Wayne Grody, who completed his two-year term. Additionally, Gerald Feldman will serve as president-elect during Herman's two-year term, and the ACMG also added several new members to its board.

Herman was a member of the ACMG's board of directors from 2001 to 2007. Herman is a professor in the department of pediatrics at Nationwide Children's Hospital and Ohio State University. She has also served as director of the Division and Center for Molecular and Human Genetics in the Department of Pediatrics. She holds an MD and PhD in biochemistry from Duke University.

The new board members ACMG named this week include Joel Charrow, who is the director of the division of genetics, birth defects, and metabolism and the genetics laboratory at the Children's Hospital of Chicago, and a professor of pediatrics at Northwestern University's Fienberg School of Medicine; Kristin Monaghan, who is director of the DNA diagnostic laboratory and a medical geneticist in the department of medical genetics at Henry Ford Hospital; Lorraine Potocki, a professor in the department of molecular and human genetics at Baylor College of Medicine and a consulting geneticist at the Texas Children's Hospital; Maren Scheuner, who is chief of medical genetics and director of health services genomics research at the VA Greater Los Angeles Healthcare System and director of clinical genetic services for the Veterans Integrated Service Network 22; and Robert Steiner, who is a professor of pediatric research and a faculty member in molecular and medical genetics and cellular biosciences at Oregon Health and Science University.


Halozyme Therapeutics has appointed Matt Posard to its board of directors. Posard is currently senior vice president and general manager of Illumina's Translational and Consumer Genomics unit. Before joining Illumina, he held a variety of positions within product marketing at Gen-Probe, and oversaw marketing at Biosite. He holds a BA in quantitative economics and decision science from the University of California, San Diego.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.